Renaissance Technologies’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-85,680
Closed -$1.52M 3524
2025
Q2
$1.52M Buy
85,680
+27,949
+48% +$544K ﹤0.01% 2282
2025
Q1
$1.2M Buy
57,731
+41,231
+250% +$782K ﹤0.01% 2295
2024
Q4
$305K Sell
16,500
-27,025
-62% -$520K ﹤0.01% 3039
2024
Q3
$853K Buy
+43,525
New +$866K ﹤0.01% 2541
2024
Q1
Sell
-90,773
Closed -$1.54M 3726
2023
Q4
$1.54M Buy
+90,773
New +$1.8M ﹤0.01% 2109
2023
Q3
Sell
-17,701
Closed -$332K 3688
2023
Q2
$332K Buy
17,701
+801
+5% +$16.2K ﹤0.01% 3086
2023
Q1
$345K Sell
16,900
-86,909
-84% -$1.75M ﹤0.01% 3062
2022
Q4
$2.2M Buy
+103,809
New +$2.15M ﹤0.01% 2013

Other funds holding BTAL

Renaissance Technologies's BTAL Position: Q3 2025 in Review

Renaissance Technologies sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 85,680 shares — an estimated $1.52M sold.

Renaissance Technologies first reported a position in BTAL in Q4 2022 and held it in 8 quarters. The position peaked at $2.2M in Q4 2022. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.

  • Renaissance Technologies reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 85,680 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $1.52M.
  • Renaissance Technologies first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 8 quarters.
  • Renaissance Technologies's AGF US Market Neutral Anti-Beta Fund position peaked at $2.2M in Q4 2022.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.